Journal Description
Life
Life
is an international, peer-reviewed, open access journal related to fundamental themes in life sciences from basic to applied research, published monthly online by MDPI. The Spanish Association for Cancer Research (ASEICA) is affiliated with Life and its members receive a discount on the article processing charges.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, CAPlus / SciFinder, and other databases.
- Journal Rank: JCR - Q1 (Biology) / CiteScore - Q1 (Paleontology)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 15.3 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the first half of 2026).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
- Testimonials: See what our editors and authors say about Life.
Impact Factor:
3.9 (2025);
5-Year Impact Factor:
3.9 (2025)
Latest Articles
Can Chronic Pain Accelerate Chronic Kidney Disease? Is Pain a Disease Modifier Rather than a Symptom?
Life 2026, 16(8), 1354; https://doi.org/10.3390/life16081354 (registering DOI) - 18 Aug 2026
Abstract
Chronic pain is one of the most common and disabling complications of chronic kidney disease (CKD), yet it is almost exclusively viewed as a consequence of declining kidney function. This perspective overlooks the possibility that chronic pain itself may influence the biological processes
[...] Read more.
Chronic pain is one of the most common and disabling complications of chronic kidney disease (CKD), yet it is almost exclusively viewed as a consequence of declining kidney function. This perspective overlooks the possibility that chronic pain itself may influence the biological processes driving CKD progression. Chronic pain is being recognized as a systemic disorder characterized by sustained neuroimmune activation, inflammation, oxidative stress, endothelial dysfunction, autonomic imbalance, mitochondrial impairment and maladaptive behavioral changes. These same mechanisms are also central to progressive kidney injury, raising the possibility that persistent pain may reinforce established pathogenic pathways rather than simply accompany them. We propose a conceptual framework in which chronic pain functions as a disease modifier capable of amplifying the biological and clinical processes that contribute to CKD progression. Although this hypothesis does not imply that chronic pain directly causes CKD or that pain management is inherently renoprotective, it provides a biologically plausible rationale for investigating whether pain contributes to disease progression beyond serving as a marker of disease severity. Exploring this possibility may broaden current concepts of CKD progression and identify new directions for mechanistic, translational and clinical research.
Full article
(This article belongs to the Special Issue CKD and Glomerular Diseases)
Open AccessArticle
Foliar Selenium Application Enhances Wheat Resistance to Bipolaris sorokiniana-Induced Spot Blotch via Modulation of Growth, Physiological Homeostasis, and Antioxidant Defense Systems
by
Muhammad Raheel, Hafiz Muhammad Usman Aslam, Saba Aslam, Waqas Ashraf, Kamran Ikram, Tahira Abbas, Muhammad Zeeshan Mansoor, Qamar uz Zaman, Muhammad Umar Alvi, Sajjad Ahmad and Hafiz Muhammad Aatif
Life 2026, 16(8), 1353; https://doi.org/10.3390/life16081353 - 17 Aug 2026
Abstract
Spot blotch has become a major devastating disease in wheat. In the current study, Faisalabad-08 was supplemented with various levels of selenium (Se) both in vitro and in greenhouse experiments (CRD, n = 3) to counter the spot blotch pathogen. The results revealed
[...] Read more.
Spot blotch has become a major devastating disease in wheat. In the current study, Faisalabad-08 was supplemented with various levels of selenium (Se) both in vitro and in greenhouse experiments (CRD, n = 3) to counter the spot blotch pathogen. The results revealed that minimum disease incidence was assessed in the case of T2 (50 mg L−1). However, maximum plant growth attributes, including plant height (PH), plant fresh weight (PFW), plant dry weight (PDW), leaf surface area (LSA), and root length (RL), were recorded in T5 (50 mg L−1 + pathogen). Similarly, chlorophyll a, chlorophyll b, total chlorophyll, membrane stability index, carotenoid, relative water contents, proline, sugar, flavonoid, total phenolic content, SOD, POD, CAT, PPO, and PAL contents were enhanced in T5 compared to other tested treatments. However, MDA, an oxidative damage marker, was significantly decreased with T5. Correlation, PCA, and heatmap analysis suggested that all the attributes were significantly interrelated, except MDA, in defining the crop’s potential to sustain its growth under biotic stress. In crux, foliar Se application (50 mg L−1) effectively mitigates spot blotch through enhanced antioxidant defense and physiological homeostasis. This sustainable approach offers a viable alternative to conventional fungicides for integrated wheat disease management.
Full article
(This article belongs to the Section Plant Science)
►▼
Show Figures

Figure 1
Open AccessArticle
Linking Embodiment, Simulator Sickness, and EEG Activity During XR–BCI Use: A Single-Participant Case Study
by
Diogo João Tomás, Miguel Pais-Vieira and Carla Pais-Vieira
Life 2026, 16(8), 1352; https://doi.org/10.3390/life16081352 - 17 Aug 2026
Abstract
Background: Subjective experience is increasingly recognised as an important component of brain–computer interface (BCI) performance in extended reality (XR) environments. Although embodiment and simulator sickness are known to influence user experience, their relationships with cortical activity during XR–BCI operation remain poorly understood. Building
[...] Read more.
Background: Subjective experience is increasingly recognised as an important component of brain–computer interface (BCI) performance in extended reality (XR) environments. Although embodiment and simulator sickness are known to influence user experience, their relationships with cortical activity during XR–BCI operation remain poorly understood. Building upon our previous investigations of embodiment and simulator sickness in XR–BCIs, the present study examined whether these subjective dimensions are associated with distinct neurophysiological patterns during repeated XR–BCI use in a participant with chronic spinal cord injury (SCI). Methods: Seventeen XR–BCI sessions performed by a participant with chronic complete SCI were analysed. Bayesian correlation analyses examined associations among embodiment, simulator sickness, BCI performance, and EEG activity. Multiple linear regression was used to identify variables independently associated with sensorimotor beta activity, and the robustness of the regression findings was evaluated using bootstrap estimation and leave-one-out sensitivity analyses. Results: Bayesian analyses identified two principal patterns of association. Sense of embodiment was positively associated with frontal theta activity (F3), whereas simulator sickness showed a negative association with sensorimotor beta activity (C3–C4). As expected, classifier acquisition accuracy was strongly associated with subsequent BCI performance. Multiple regression demonstrated that simulator sickness was the only variable independently associated with C3–C4 beta activity after accounting for embodiment and BCI performance. This association remained robust following bootstrap estimation and leave-one-out sensitivity analyses. Conclusions: Although limited to a single participant, these findings suggest that different dimensions of subjective experience during XR–BCI operation are associated with partially distinct neurophysiological correlates. In particular, simulator sickness was the variable most consistently associated with sensorimotor beta activity across all analyses. These findings provide a foundation for future longitudinal investigations of the neural mechanisms linking subjective experience and cortical dynamics during XR–BCI use.
Full article
(This article belongs to the Special Issue Neural Mechanisms of Brain–Computer Interfaces)
►▼
Show Figures

Figure 1
Open AccessArticle
Effects of Fertilizer Rates on Growth of Brassica napus L.
by
Yumei Xu, Yuqi Liu, Wenqing Tan, Guangyao Chen, Lei Qin, Yufang Li and Rongkui Hui
Life 2026, 16(8), 1351; https://doi.org/10.3390/life16081351 - 17 Aug 2026
Abstract
The edible oil self-sufficiency rate of China is only approximately 30%, with rapeseed as the largest source of edible oil, contributing more than half of the total edible vegetable oil. Therefore, it is very important to achieve high rapeseed yield to ensure supply
[...] Read more.
The edible oil self-sufficiency rate of China is only approximately 30%, with rapeseed as the largest source of edible oil, contributing more than half of the total edible vegetable oil. Therefore, it is very important to achieve high rapeseed yield to ensure supply security. Fertilizer is one of the key factors affecting rapeseed yield and quality, and the appropriate use of fertilizer is essential for ensuring both high yield and high quality. To investigate the effects of fertilizer rates on the growth, yield, and quality of rapeseed, 18 rapeseed varieties were grown under two fertilizer input levels: normal fertilizer (NF, 15-15-15 NPK compound fertilizer at 600 kg·ha−1) and high fertilizer (HF, 15-15-15 NPK compound fertilizer at 1200 kg·ha−1). Agronomic traits, physiological indicators, yield, and quality of these varieties were systematically analyzed in this study. In addition, transcriptomic data from stems collected at the silique stage were used to identify key differentially expressed genes (DEGs), and the correlations between the expression levels of these candidate genes, physiological indicators, agronomic traits, and yield were examined. Compared with the NF treatment, the HF treatment promoted rapeseed growth during the bolting stage (except for root collar diameter). At harvest, 27.8% of the rapeseed varieties showed a significant increase in the number of effective branches per plant, while 33.3% exhibited significant increases in both the number of effective siliques per plant and the yield per plant. Among these varieties, Z01, Z02, Huayouza 50, and Huayouza 652 showed the greatest overall yield increases. The oil content decreased in 88.9% of the varieties, whereas the unsaturated fatty acid content increased in 77.8%, and the protein content increased in 94.4% of the varieties. Under HF treatment, superoxide dismutase activity in leaves at the bolting stage and peroxidase activity in leaves at the initial flowering stage both increased significantly (by 19.07% and 10.41%, respectively). The content of thiobarbituric acid-reactive substances (expressed as malondialdehyde equivalents) in stems at the initial flowering stage increased significantly (by 138.39%). In addition, catalase activity in leaves at the 3- to 4-leaf stage reached its highest value among all treatments (27.31 U·g−1·min−1·FW). The KEGG enrichment analysis indicated that the DEGs were significantly enriched in secondary metabolite biosynthesis, plant hormone signal transduction, plant–pathogen interactions, and metabolic pathways. Through screening against the NCBI database and subsequent validation by RT-qPCR, we ultimately identified four candidate DEGs: BnaC05g02370D, BnaC09g49910D, BnaC03g45470D, and BnaA04g00130D. Among these four varieties, catalase activity and malondialdehyde content in rapeseed stems at the initial flowering stage showed significant positive correlations with yield (r = 0.738 and r = 0.894, respectively). BnaC09g49910D maintained a consistently positive correlation with yield under both the HF and NF treatments (r = 0.977 and r = 0.806, respectively). In contrast, the direction of the association for BnaC05g02370D reversed depending on the fertilizer level (r = −0.858 under HF vs. r = 0.443 under NF). Catalase activity and the content of thiobarbituric acid-reactive substances in stems at the initial flowering stage and the expression levels of BnaC05g02370D and BnaC09g49910D in stems at the silique stage are associated with yield to varying degrees. These indicators can be used as candidate traits for assessing rapeseed yield potential under different fertilizer input levels.
Full article
(This article belongs to the Section Plant Science)
►▼
Show Figures

Figure 1
Open AccessReview
The Kynurenine Pathway in Tuberculosis: Focus on Immunometabolic Regulation, Compartment-Specific Biology, and Therapeutic Potential
by
Piotr Stasiak, Kacper Kraśnik, Maciej Biskupski, Aleksandra Tarka, Michał Flis and Ewa M. Urbańska
Life 2026, 16(8), 1350; https://doi.org/10.3390/life16081350 - 17 Aug 2026
Abstract
Tuberculosis (TB) remains a global health problem, and attention is focused on host immunometabolic pathways influencing antimicrobial immunity, tissue injury, and treatment response. This comprehensive review integrates evidence on the kynurenine pathway (KP) of tryptophan (TRP) metabolism in TB and evaluates its potential
[...] Read more.
Tuberculosis (TB) remains a global health problem, and attention is focused on host immunometabolic pathways influencing antimicrobial immunity, tissue injury, and treatment response. This comprehensive review integrates evidence on the kynurenine pathway (KP) of tryptophan (TRP) metabolism in TB and evaluates its potential as a host-directed therapeutic target. Evidence from human cohorts, in vitro systems, animal models, and non-human primates indicates that Mycobacterium tuberculosis activates the KP across myeloid, antigen-presenting, non-hematopoietic lung, granulomatous, pleural, and central nervous system compartments. KP activation is shaped by interferon-γ signaling, mycobacterial burden, infection duration, strain virulence, and host regulatory mechanisms. Increased indoleamine 2,3-dioxygenase-related (IDO) activity, TRP depletion, kynurenine accumulation, and kynurenine–aryl hydrocarbon receptor (AhR) signaling are associated with impaired T-cell proliferation and recruitment, suppressive myeloid phenotypes, and spatially restricted immunoregulatory niches within granulomas. Accumulated data indicate context-dependent protective effects of the KP manipulations, through restriction of excessive inflammation. Furthermore, the KP-related changes may have biomarker value. Integrated assessment of enzyme expression, kynurenine-to-tryptophan ratio (K/T ratio), downstream metabolites, and signaling pathways will be essential for translational studies. Future studies should therefore evaluate KP activity using integrated readouts, including IDO expression, metabolites and their ratios, and KYN–AhR signaling, and should determine whether context-specific pathway modulation can safely improve outcomes when combined with conventional anti-TB therapy.
Full article
(This article belongs to the Special Issue Multifaceted Role of Tryptophan-Kynurenine Pathway in Metabolism and Human Health: From Molecular Targets to Therapeutic Interventions)
►▼
Show Figures

Figure 1
Open AccessArticle
Stellate Ganglion Block Combined with Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss: A Retrospective Three-Arm Study
by
Geng-He Chang, Chung-Hang Wong, An-Ting Lee, Yu-Ching Cheng and Wen-Chun Liu
Life 2026, 16(8), 1349; https://doi.org/10.3390/life16081349 - 17 Aug 2026
Abstract
Sudden sensorineural hearing loss (SSNHL) carries unpredictable recovery, and adjunctive therapies beyond systemic corticosteroids are limited. Stellate ganglion block (SGB) and hyperbaric oxygen therapy (HBOT) have each been proposed as adjuncts, yet their combined effect remains poorly characterized. A retrospective three-arm cohort study
[...] Read more.
Sudden sensorineural hearing loss (SSNHL) carries unpredictable recovery, and adjunctive therapies beyond systemic corticosteroids are limited. Stellate ganglion block (SGB) and hyperbaric oxygen therapy (HBOT) have each been proposed as adjuncts, yet their combined effect remains poorly characterized. A retrospective three-arm cohort study (IRB No. 202401644B0) enrolled 75 SSNHL patients: Control (standard corticosteroid, n = 39), SGB (n = 21), and SGB+HBOT (n = 15). PTA4 improvement and Siegel recovery categories were assessed at two weeks, one month, and two months. Subgroup analyses stratified patients by baseline PTA4 < 70 dB and ≥70 dB. Groups differed significantly in overall baseline PTA4 (Kruskal–Wallis p = 0.044; SGB group worst at 80.4 ± 17.3 dB) and in diabetes mellitus (DM) prevalence (Control 44% vs. 7% in SGB+HBOT; p = 0.018). Within the ≥70 dB subgroup, baseline PTA4 was balanced across groups (Control 86.5 ± 13.0 dB, SGB 88.2 ± 14.2 dB, SGB+HBOT 90.9 ± 15.3 dB; p = 0.748). In this balanced stratum, SGB+HBOT achieved the greatest two-month PTA4 improvement (+23.6 ± 27.2 dB) and the highest complete recovery rate (43%, 3/7), versus 27% (3/11) in Control and 9% (1/11) in SGB. No statistically significant between-group differences were identified. However, SGB+HBOT demonstrated the numerically greatest audiometric improvement and the highest complete recovery rate in the severe–profound subgroup despite baseline disadvantages, suggesting a possible therapeutic benefit for this population. These exploratory findings support prospective evaluation in an adequately powered randomized controlled trial.
Full article
(This article belongs to the Special Issue Diagnosis, Treatment and Prognosis of Head and Neck Disorders)
►▼
Show Figures

Figure 1
Open AccessArticle
Comprehensive Mechanistic Characterisation of the Antidiabetic Profile of Sutherlandia frutescens Using Target-Directed In Vitro Assays and Cellomics
by
Nadine Pringle, Trevor C. Koekemoer and Maryna van de Venter
Life 2026, 16(8), 1348; https://doi.org/10.3390/life16081348 - 17 Aug 2026
Abstract
Several studies have suggested potential mechanisms through which Sutherlandia frutescens exerts antidiabetic effects, yet much of its therapeutic potential remains unexplored. This study aimed to provide greater insights into the antidiabetic capabilities and limitations of S. frutescens through the use of a comprehensive
[...] Read more.
Several studies have suggested potential mechanisms through which Sutherlandia frutescens exerts antidiabetic effects, yet much of its therapeutic potential remains unexplored. This study aimed to provide greater insights into the antidiabetic capabilities and limitations of S. frutescens through the use of a comprehensive in vitro screening platform incorporating target-directed assays with automated image cytometry and analysis, where relevant. The antidiabetic effects of a crude hot aqueous extract of S. frutescens were assessed across well-characterised targets representing prominent hallmarks of diabetes: postprandial hyperglycaemia, insulin sensitivity, β-cell dysfunction, chronic inflammation and adipose tissue dysfunction. The findings revealed S. frutescens as a multicomponent therapeutic, with its individual target activities being relatively subtle and a few appearing novel. Notably, however, S. frutescens inhibited multiple targets relevant to postprandial hyperglycaemia—including carbohydrate digestion (29.1% and 26.4% inhibition for sucrose and maltose, respectively, at 500 µg/mL), intestinal glucose uptake in Caco-2 cells (between 9.51% and 20.92% reduction from 100 to 500 µg/mL) and protein glycation (23.2% inhibition at 200 µg/mL)—activities not previously documented in vivo. Glucose consumption in C3A hepatocytes showed a dose-dependent increase in glucose consumption from 12.5 to 100 µg/mL. Glucose consumption was reduced in palmitic acid-induced insulin-resistant L6 skeletal muscle cells from 100% to 69.57%, while 50 µg/mL S. frutescens restored it to 97.84%. S. frutescens also enhanced INS-1 β-cell survival under oxidative stress at concentrations as low as 12.5 µg/mL. The integration of automated image cytometry and analysis provides a novel approach with which to characterise its antidiabetic properties and elucidate its potential molecular mechanisms. Overall, S. frutescens is shown to impact several interrelated mechanisms simultaneously, suggesting that the coordinated modulation of multiple pathways may contribute to its overall biological activity. Whether these effects are additive or synergistic remains to be determined.
Full article
(This article belongs to the Special Issue Bioactive Phytotherapeutics in Metabolic and Inflammatory Disorders)
►▼
Show Figures

Figure 1
Open AccessArticle
Age, Sex, and Laterality-Based Evaluation of Renal Volume and Surface Area Using CT-Based Three-Dimensional Segmentation
by
Ayse Gamze Ozcan, Busra Pirinc, Betul Sevindik, Ekrem Solmaz, Mustafa Koplay and Ahmet Kagan Karabulut
Life 2026, 16(8), 1347; https://doi.org/10.3390/life16081347 - 17 Aug 2026
Abstract
Background: The kidneys maintain systemic homeostasis, making renal size assessment essential for evaluating various disorders. Renal volume represents a critical morphometric parameter with distinct clinical significance. This study investigated age-, sex-, and laterality-related differences in renal volume and surface area within an adult
[...] Read more.
Background: The kidneys maintain systemic homeostasis, making renal size assessment essential for evaluating various disorders. Renal volume represents a critical morphometric parameter with distinct clinical significance. This study investigated age-, sex-, and laterality-related differences in renal volume and surface area within an adult population. Methods: A total of 582 kidneys from 291 individuals aged 19 to 89 who underwent abdominal CT scans were retrospectively examined. The images were imported into the 3D Slicer software (version 5.6.2) in DICOM format, and automatic segmentation was performed using the Total Segmentator module. The volumes and surface areas of both kidneys were measured and compared according to age and sex groups. Results: Kidney volume and surface area values were found to be significantly higher in men than in women (p < 0.05). This difference was particularly pronounced in the 30–69 age range. The highest volume values were found in women in the 40–49 age group, while in men, they were found in the 30–59 age group. However, in groups over seventy years old, the gender difference lost its statistical significance. Additionally, the left kidney was found to be significantly larger than the right kidney (p < 0.05). As age increases, a gradual decrease in kidney volume and surface area is observed in both sexes. Conclusions: The progressive decline in renal metrics and the disappearance of sex-based differences after 70 years align with age-related parenchymal atrophy, nephron loss, and reduced blood flow. These findings support the establishment of data baselines for clinical monitoring and surgical planning.
Full article
(This article belongs to the Section Medical Research)
►▼
Show Figures

Figure 1
Open AccessReview
Artificial Intelligence and Digital Pathology: Technological Transformation and Strategic Impact in Clinical Research and Medical Affairs
by
Carmela Baviello, Daniela Maria Capuano and Roberto Verna
Life 2026, 16(8), 1346; https://doi.org/10.3390/life16081346 - 16 Aug 2026
Abstract
The progressive integration of Whole Slide Imaging (WSI) technology and Artificial Intelligence (AI) architectures is driving a structural transformation in pathology and precision oncology. This structured critical review analyzes and systematizes the impact of this technological transition along two fundamental operational dimensions of
[...] Read more.
The progressive integration of Whole Slide Imaging (WSI) technology and Artificial Intelligence (AI) architectures is driving a structural transformation in pathology and precision oncology. This structured critical review analyzes and systematizes the impact of this technological transition along two fundamental operational dimensions of the modern biopharmaceutical industry: pre-registration Clinical Research and post-launch strategies governed by Medical Affairs. The first section explores how computational pathology is improving efficiency and reducing risk in drug development. Replacing analog visual assessment—intrinsically subject to inter-observer and intra-observer variability—with quantitative algorithms for cellular classification and segmentation enables optimization of patient recruitment in clinical trials, reducing screening failure rates. This review also examines the emerging role of Spatial Biology in extracting complex topological metrics from the Tumor Microenvironment (TME) and the use of AI for the objective and auditable quantification of critical surrogate endpoints, such as Pathological Complete Response (pCR), while acknowledging that algorithmic precision remains sensitive to pre-analytical variables and dataset biases. In the second section, the study investigates the strategic evolution of Medical Affairs, acting as a vital scientific communication and translational bridge between the complexity of Data Science and clinical hospital practice. Challenges related to AI adoption by clinicians are examined, emphasizing the importance of educational programs based on Explainable AI (XAI) to overcome the cognitive limitations of the black-box paradigm and the complex regulatory validation pathway for Software as a Medical Device (SaMD) under the stringent European IVDR framework—supported by an analysis of historical regulatory benchmarks such as the Paige Prostate case. The paper also explores the potential of AI in the large-scale generation of Real-World Evidence (RWE), applied to the creation of synthetic control arms in pharmacoeconomic settings. In conclusion, the study highlights that the diagnostic algorithm has ceased to be merely a laboratory support tool and has become a strategic asset and an integral adjunct to therapeutic decision-making. Overcoming current challenges related to data privacy through Federated Learning architectures, together with the imminent transition toward Foundation Models, foreshadows a fully data-driven healthcare ecosystem, making continuous skills development (digital upskilling) an essential requirement for professionals in the biopharmaceutical sector.
Full article
(This article belongs to the Section Artificial Intelligence in the Life Sciences)
►▼
Show Figures

Figure 1
Open AccessReview
Depression-Related Mechanistic and Translational Evidence for Centella asiatica and Its Triterpenoids: A Scoping Review
by
Pimol Kanchalearnpong, Auemphon Mordmuang, Lavanya Goodla and Weeratian Tawanwongsri
Life 2026, 16(8), 1345; https://doi.org/10.3390/life16081345 - 16 Aug 2026
Abstract
Background: Depression is a multifactorial psychiatric disorder involving monoaminergic, neurotrophic, inflammatory, oxidative, and stress-response pathways. Centella asiatica and its triterpenoids have demonstrated neuroprotective and stress-modulating properties, but depression-focused evidence remains fragmented. Objective: The aim of this scoping review was to map the available
[...] Read more.
Background: Depression is a multifactorial psychiatric disorder involving monoaminergic, neurotrophic, inflammatory, oxidative, and stress-response pathways. Centella asiatica and its triterpenoids have demonstrated neuroprotective and stress-modulating properties, but depression-focused evidence remains fragmented. Objective: The aim of this scoping review was to map the available evidence on C. asiatica, its standardized extracts, and its bioactive triterpenoids in relation to depression-related outcomes and mechanisms. Methods: A protocol was registered before formal screening, full-text assessment, data charting, and evidence synthesis (INPLASY202670003). Scopus, PubMed/MEDLINE, the Cochrane Library, and ClinicalTrials.gov were searched from inception to 2 July 2026. Eligible studies included human, animal, cell-based, and ex vivo studies reporting depression, depressive-like behavior, antidepressant-like effects, or mechanisms explicitly linked to depression-related pathophysiology. Two reviewers independently screened the identified records and charted the data using a standardized form, with disagreements resolved through consensus or consultation with a third reviewer. The findings were synthesized descriptively and narratively. Results: A total of 14 studies published between 2008 and 2025 were included, comprising 13 preclinical studies and 1 open-label human study. No eligible cell-based or ex vivo studies were identified. The included studies primarily examined C. asiatica extracts and isolated triterpenoids, particularly asiaticoside and asiatic acid. Most studies reported favorable depression-related or antidepressant-like findings. The principal reported mechanisms involved BDNF/CREB-related signaling and neuroplasticity, monoaminergic regulation, attenuation of neuroinflammation and oxidative stress, and modulation of the hypothalamic–pituitary–adrenal axis. However, the evidence base is heterogeneous and predominantly derived from animal models. Conclusions: The available evidence supports the biological plausibility and preclinical antidepressant-like activity of C. asiatica and its triterpenoids; however, the evidence remains insufficient to establish clinical efficacy in humans. Future studies should prioritize standardized preparations, dose justification, pharmacokinetic and safety evaluation, validated depression-specific outcomes, and rigorously controlled clinical trials.
Full article
(This article belongs to the Special Issue Therapeutic Innovations from Plants and Their Bioactive Extracts)
►▼
Show Figures

Figure 1
Open AccessArticle
Influence of Translocator Protein (TSPO) and rs6971 Variant on Methamphetamine Addiction and Methamphetamine-Associated Psychosis in Turkish Population
by
Emine Merve Akdağ, Ceren Gümüş, Esra Boztepe, Rukiye Ay Diker and Dilek Pirim
Life 2026, 16(8), 1344; https://doi.org/10.3390/life16081344 - 16 Aug 2026
Abstract
Background: Translocator Protein (TSPO) is a transmembrane protein located in the mitochondrial outer membrane and highly expressed in the brain, which makes it a potential biomarker for microglial activation and neuroinflammation in neurodegenerative diseases. However, its role in neuropsychiatric disorders and its contribution
[...] Read more.
Background: Translocator Protein (TSPO) is a transmembrane protein located in the mitochondrial outer membrane and highly expressed in the brain, which makes it a potential biomarker for microglial activation and neuroinflammation in neurodegenerative diseases. However, its role in neuropsychiatric disorders and its contribution to methamphetamine (METH) addiction (MA) remain unclear. Here, we aimed to investigate the association of the TSPO rs6971 with susceptibility to MA and METH-associated psychosis (MAP) and to evaluate its effect on TSPO expression. Methods: We investigated the association of TSPO/rs6971 (Ala147Thr) with susceptibility to MA and METH-associated psychosis (MAP). Genotyping was performed on 300 individuals, including 200 diagnosed with METH use disorder, with 100 of these exhibiting MAP, along with 100 healthy controls (HCs). We explored how different genotypes influence TSPO expression at both the transcript and protein levels using RT-qPCR and ELISA. Results: Age- and sex-adjusted logistic regression analysis revealed nominal associations between the rs6971 AA genotype and MAP under the recessive and co-dominant genetic models, with stronger associations observed after excluding individuals with a family history of psychiatric disorders. Within the MAP group, carriers of the A allele exhibited increased circulating TSPO levels compared to those with the GG genotype. Additionally, higher protein concentrations (p = 0.036) were observed in heterozygous individuals with MAP, compared to METH users without psychosis. Conclusions: Our findings suggest that the expression of TSPO may be influenced by genotype, with A allele carriers showing elevated TSPO expression. Overall, these exploratory findings suggest potential for TSPO-based translational strategies for patients with MA, and highlight the need for more comprehensive evaluations in future research.
Full article
(This article belongs to the Section Genomics and Proteomics)
►▼
Show Figures

Figure 1
Open AccessSystematic Review
Effects of Linagliptin on Liver Enzymes in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
by
Moragot Chatatikun, Ratana Netphakdee, Aman Tedasen, Jason C. Huang, Wiyada Kwanhian Klangbud, Jongkonnee Thanasai and Atthaphong Phongphithakchai
Life 2026, 16(8), 1343; https://doi.org/10.3390/life16081343 - 16 Aug 2026
Abstract
Type 2 diabetes mellitus (T2DM) is often linked to metabolic dysfunction-associated steatotic liver disease (MASLD), a metabolic liver condition defined by excessive lipid deposition within hepatocytes and is frequently accompanied by increased circulating liver enzyme levels. Dipeptidyl peptidase-4 (DPP-4) inhibitors, such as linagliptin,
[...] Read more.
Type 2 diabetes mellitus (T2DM) is often linked to metabolic dysfunction-associated steatotic liver disease (MASLD), a metabolic liver condition defined by excessive lipid deposition within hepatocytes and is frequently accompanied by increased circulating liver enzyme levels. Dipeptidyl peptidase-4 (DPP-4) inhibitors, such as linagliptin, may exert pleiotropic effects on hepatic metabolism; however, their effects on liver enzyme profiles remain uncertain. This systematic review and meta-analysis aimed to evaluate the impact of linagliptin on liver enzymes, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT), in patients with T2DM. A systematic literature search was performed across five electronic databases up to 11 May 2026 following the PRISMA 2020 guidelines. Randomized controlled trials and cohort studies were included, and pooled mean differences (MDs) were calculated using random-effects models. Eight studies involving 1262 participants were analyzed. Linagliptin was associated with a modest reduction in AST (MD −1.58 U/L, 95% CI −2.85 to −0.31) with low heterogeneity, whereas the change in ALT was not statistically significant (MD −1.86 U/L, 95% CI −4.14 to 0.42), and substantial heterogeneity was observed. No significant effects were observed for GGT, while evidence for ALP was limited to a single study and was insufficient to determine the effect of linagliptin. Overall, linagliptin demonstrated limited and inconsistent effects on liver enzyme profiles.
Full article
(This article belongs to the Section Pharmaceutical Science)
►▼
Show Figures

Figure 1
Open AccessArticle
Administration of the Postbiotic Substance 412 to Slovak Warm-Blooded Horses: A Pilot Experiment
by
Andrea Lauková, Valentína Focková, Lenka Micenková, Soňa Gancarčíková, Iveta Plachá, Ľubomíra Grešáková, Anton Kováčik, Marko Halo, Branislav Gálik and Monika Pogány Simonová
Life 2026, 16(8), 1342; https://doi.org/10.3390/life16081342 - 16 Aug 2026
Abstract
Antimicrobial proteinaceous postbiotic substances (PS) and/or bacteriocins can beneficially influence animal health, as previously shown with enterocins from non-autochthonous enterococcal strains. Therefore, the effectiveness of PS 412, produced by our beneficial autochthonous strain Enterococcus faecium EF 412, was assessed in horses. In the
[...] Read more.
Antimicrobial proteinaceous postbiotic substances (PS) and/or bacteriocins can beneficially influence animal health, as previously shown with enterocins from non-autochthonous enterococcal strains. Therefore, the effectiveness of PS 412, produced by our beneficial autochthonous strain Enterococcus faecium EF 412, was assessed in horses. In the pilot experiment, PS 412 was administered to 12 horses of various ages and breeds for 21 days via a small feed ball. Sampling was performed on days 0/1, 21, and 42 (after a 3-week cessation of PS 412). The horses served as their own controls. Although the number of horses was limited, the microbiological analysis showed significant decreases in enterococci, other lactic acid bacteria, and campylobacters (p < 0.05; p < 0.001). Staphylococci decreased slightly. Coliforms, aeromonads (p < 0.001), and pseudomonads also decreased. In next-generation sequencing at the phylum level, 15 phyla were detected at higher abundance, with Bacteroidota (35.38%) and Bacillota (32.25%) the most abundant. After PS 412 (activity 51,200 AU/mL), the relative abundance of several phyla decreased. On day 21, phagocytic activity was higher (69.00 ± 3.91%). The metabolic profiles and hematologic values were mostly within the reference range. Although continued testing is necessary, postbiotics appear to be a tool for supporting equine health.
Full article
(This article belongs to the Special Issue Horse: Health and Disease)
►▼
Show Figures

Figure 1
Open AccessArticle
Effects of a Phytogenic Water Supplement on Selected Cultivable Bacterial Populations and Intestinal Histomorphology in Ross 308 Broiler Chickens Challenged with Salmonella Typhimurium
by
Cristina-Elena Horhogea, Ivona Popovici, Geta Pavel, Carmen Solcan, Lenuța Fotea, Mariana Grecu, Erzsébet Varga, Ibolya Fülöp, Dragoș-Constantin Aniță and Cristina-Mihaela Rîmbu
Life 2026, 16(8), 1341; https://doi.org/10.3390/life16081341 - 16 Aug 2026
Abstract
Increasing antimicrobial resistance and restrictions on antibiotic use in poultry have drawn attention to phytogenic products as a complementary approach for controlling enteric bacterial infections. The aim of this study was to evaluate the effects of a phytogenic product (Herba Top Salmonella, HTS)
[...] Read more.
Increasing antimicrobial resistance and restrictions on antibiotic use in poultry have drawn attention to phytogenic products as a complementary approach for controlling enteric bacterial infections. The aim of this study was to evaluate the effects of a phytogenic product (Herba Top Salmonella, HTS) on selected cultivable intestinal bacterial populations, intestinal histomorphology and tissue distribution of Salmonella Typhimurium in experimentally infected broiler chickens. A total of sixty one-day-old Ross 308 broilers were randomly assigned to six experimental groups (10 birds/group; two pens/group, five birds/pen, with the pen considered the experimental unit. Birds in three groups were experimentally challenged with Salmonella enterica subsp. enterica serovar Typhimurium, and HTS was administered in drinking water for 14 consecutive days at two nominal concentrations (3 mL/L and 6 mL/L). Intestinal microbiological parameters, histomorphometric characteristics, and the presence of Salmonella Typhimurium in tissues by immunohistochemistry were evaluated. The effects of infection status, HTS concentration, and their interaction were analyzed using two-way ANOVA. HTS administration was associated with reduced counts of total aerobic bacteria, Escherichia coli and Enterobacteriaceae counts. In experimentally infected broilers, HTS treatment was also associated with reduced Salmonella Typhimurium in intestinal tissue and significant changes in intestinal histomorphometric parameters, including increased crypt depth and mitotic activity. The observed responses were influenced by both infection status and the HTS nominal concentration. Because of the limited number of independent experimental units and the absence of individual HTS intake measurements, these findings should be considered exploratory preliminary findings, and further studies with larger animal groups under commercial production conditions are required.
Full article
(This article belongs to the Special Issue Antimicrobial Innovations)
►▼
Show Figures

Figure 1
Open AccessSystematic Review
Exploring the Involvement of ERAP1 in the Pathogenesis of Non-Infectious Uveitis: A Systematic Review
by
Ioana-Maria Rizea, Horia Tudor Stanca, Vasile Potop, Dana-Margareta-Cornelia Dăscălescu, Silvia Ioana Andrei, Ioana Teodora Tofolean, Alina Popa-Cherecheanu, Mihnea Munteanu, Marius Cherciu and Olivia-Mihaela Popa
Life 2026, 16(8), 1340; https://doi.org/10.3390/life16081340 - 16 Aug 2026
Abstract
Background: Non-infectious uveitis (NIU) is an inflammatory ocular condition often associated with systemic immune-mediated disorders. The pathogenesis of NIU is complex and involves genes from the Human Leukocyte Antigen (HLA) class I system. Endoplasmic reticulum aminopeptidase 1 (ERAP1) cleaves antigenic peptides to
[...] Read more.
Background: Non-infectious uveitis (NIU) is an inflammatory ocular condition often associated with systemic immune-mediated disorders. The pathogenesis of NIU is complex and involves genes from the Human Leukocyte Antigen (HLA) class I system. Endoplasmic reticulum aminopeptidase 1 (ERAP1) cleaves antigenic peptides to an optimal length for loading and presentation on HLA I molecules. In this systematic review, we aimed to summarize the current knowledge regarding how susceptibility to developing NIU is linked to single-nucleotide polymorphisms (SNPs) in the ERAP1 gene, a locus well known for its connection to autoinflammatory disorders. Methods: We performed a PRISMA protocol-guided systematic review in various databases. Results: Out of the 311 screened studies, only 12 met the inclusion criteria. Five of them are Genome-Wide Association Studies. We found relevant research for three types of NIU: acute anterior uveitis, Behçet’s uveitis, and birdshot chorioretinopathy. A frequently observed association between ERAP1 SNPs and disease risk was noted when analyzing the HLA-carriers (B*27, B*51, A*29), which points toward an epistatic interaction between ERAP1 and the MHC class I complex. Conclusions: Our findings suggest that ERAP1 gene variation is understudied in relation to NIU. A significant amount of research has also concentrated on risk stratification, and reliable markers for patient selection are needed, especially in view of emerging anti-ERAP therapies.
Full article
(This article belongs to the Section Medical Research)
►▼
Show Figures

Figure 1
Open AccessCommunication
Platelet-Rich Plasma in Episiotomy Repair: A Critical Appraisal of a Sparse and Partly Non-Indexed Evidence Base and Rationale for a Randomized Controlled Trial
by
Dragos Brezeanu, Ana-Maria Brezeanu, Traian-Virgiliu Surdu, Monica Surdu and Vlad Tica
Life 2026, 16(8), 1339; https://doi.org/10.3390/life16081339 - 15 Aug 2026
Abstract
Background: Episiotomy remains one of the most common obstetric procedures worldwide, and suboptimal healing of the perineal wound continues to cause pain, dehiscence, and long-term impairment of postpartum quality of life. Obstetric anal sphincter injury (OASI) carries the greatest risk of severe wound
[...] Read more.
Background: Episiotomy remains one of the most common obstetric procedures worldwide, and suboptimal healing of the perineal wound continues to cause pain, dehiscence, and long-term impairment of postpartum quality of life. Obstetric anal sphincter injury (OASI) carries the greatest risk of severe wound morbidity among perineal trauma types and is managed with prophylactic antibiotics and adjunctive measures; episiotomy, by contrast, is repaired without a comparable prophylactic package and is far more frequent, so that even a modest per-case complication rate carries a substantial absolute burden. Platelet-rich plasma (PRP), an autologous concentrate rich in growth factors, has demonstrated favourable effects on wound healing and scar quality across several surgical contexts, including caesarean section, raising the question of whether it could similarly benefit episiotomy repair. Methods: We conducted a structured, date-stamped search of PubMed, Scopus and Google Scholar, together with two trial registries (ClinicalTrials.gov, WHO ICTRP), forward and backward citation tracking, and reference-list screening of relevant reviews (final search 24 July 2026), to identify clinical studies of PRP for obstetric episiotomy or intrapartum perineal wound healing. Results: Five primary clinical studies and one systematic review were identified. One single-centre randomized controlled trial of 200 primiparous women, published in a regionally indexed journal covered by neither PubMed nor Scopus, evaluated PRP specifically for episiotomy wound healing and reported significantly lower REEDA, Vancouver and pain scores in the PRP arm; it was not prospectively registered, reported neither a sample-size calculation nor blinded outcome assessment, lost 12% of participants to follow-up, and contains internal inconsistencies in the reported data. The remaining evidence comprises one randomized trial of PRP for postpartum levator ani muscle recovery (a distinct target, with a null result), one non-randomized comparative study in grade III–IV intrapartum perineal laceration repair, two case reports, and one broad systematic review of PRP in pelvic floor disorders in which episiotomy was not analyzed as a distinct entity. Conclusions: PRP for episiotomy healing is therefore not wholly untested, but the single existing randomized trial is small, methodologically limited, not independently replicated, and effectively invisible to conventional database searching. We describe this evidence base and introduce PRP-EpiHeal (ClinicalTrials.gov ID: NCT07669285), designed to provide the first prospectively registered, adequately powered and assessor-blinded randomized evidence on this question, with REEDA scale assessment at six weeks postpartum as the primary outcome.
Full article
(This article belongs to the Special Issue Stem Cell Biology, Tissue Formation, Cell Plasticity and Regenerative Medicine)
►▼
Show Figures

Figure 1
Open AccessReview
Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review
by
Szabolcs Kéri
Life 2026, 16(8), 1338; https://doi.org/10.3390/life16081338 - 14 Aug 2026
Abstract
Clinical trials and naturalistic studies describe psychedelics under markedly different exposure conditions. This narrative review searched PubMed/MEDLINE, the Cochrane Library, ClinicalTrials.gov, and regulatory sources through 15 July 2026, and examined safety and outcomes across four dimensions of exposure: dose, frequency, person, and context.
[...] Read more.
Clinical trials and naturalistic studies describe psychedelics under markedly different exposure conditions. This narrative review searched PubMed/MEDLINE, the Cochrane Library, ClinicalTrials.gov, and regulatory sources through 15 July 2026, and examined safety and outcomes across four dimensions of exposure: dose, frequency, person, and context. In screened adults receiving one to three supervised doses, transient headache, nausea, anxiety, and cardiovascular activation are common; serious reactions are uncommon but include persistent anxiety, suicidality signals, and a recent case of hallucinogen persisting perception disorder. Evidence supports MDMA (3,4-Methylenedioxymethamphetamine) -assisted therapy for post-traumatic stress disorder and psilocybin-based interventions for depression, although functional unblinding, selected samples, inconsistent comparators, and a recent negative primary trial constrain certainty. Naturalistic studies suggest that vulnerability and context modify outcomes, but frequency is inconsistently measured and rarely linked to cumulative exposure or long-term health. Short-term microdosing trials show limited benefit, whereas long-term cardiac and psychiatric safety remains unresolved. Exposure-defined cohorts, prospective registries, echocardiographic surveillance, and blinding-aware comparative trials are priorities.
Full article
(This article belongs to the Section Medical Research)
►▼
Show Figures

Figure 1
Open AccessArticle
Bilateral-Asymmetry-Aware Multiple-Instance Learning for Breast Cancer Classification on Chest CT
by
Ioana-Andreea Cîrlig, Lucian-Mihai Florescu, Mădălin Mămuleanu, Cristina-Mihaela Ciofiac, Mihai-Alexandru Ene, Aurelia-Ștefania Domenco, Alexandru-Marian Olaru, Alexandra-Gabriela-Cosmina Țâru, Raluca-Elena Nica, Rossy-Vlăduț Teică and Ioana-Andreea Gheonea
Life 2026, 16(8), 1337; https://doi.org/10.3390/life16081337 - 14 Aug 2026
Abstract
Incidental breast abnormalities may be visible on chest computed tomography (CT), although breast tissue is frequently outside the primary diagnostic focus of these examinations. This proof-of-concept study developed and internally evaluated a bilateral-asymmetry-aware multiple-instance learning framework (BAA-MIL) for case-level discrimination between breast cancer
[...] Read more.
Incidental breast abnormalities may be visible on chest computed tomography (CT), although breast tissue is frequently outside the primary diagnostic focus of these examinations. This proof-of-concept study developed and internally evaluated a bilateral-asymmetry-aware multiple-instance learning framework (BAA-MIL) for case-level discrimination between breast cancer and non-malignant control examinations using preselected breast-containing axial chest CT images. The retrospective single-center case–control dataset included 89 CT examinations from 89 unique patients: 49 histopathologically confirmed breast cancer cases and 40 non-malignant control cases established according to predefined case-level reference criteria. The dataset comprised 304 selected axial CT images, yielding 608 unilateral breast-region crops arranged as 304 bilateral crop pairs. Paired breast crops were processed by a shared convolutional encoder, combined through an explicit side-symmetric asymmetry descriptor, and aggregated across axial images using gated attention-based multiple-instance learning. Performance was assessed using exploratory five-fold stratified patient-level cross-validation and a nested patient-level validation analysis. Under the primary nested patient-level validation protocol, the compact-encoder BAA-MIL implementation achieved an accuracy of 0.528 (95% CI, 0.427–0.629), balanced accuracy of 0.555 (95% CI, 0.465–0.637), sensitivity of 0.286 (95% CI, 0.160–0.415), specificity of 0.825 (95% CI, 0.694–0.930), and ROC AUC of 0.547 (95% CI, 0.420–0.665). The original non-nested analysis yielded higher exploratory estimates, but this analysis used the held-out folds for early stopping and checkpoint selection and is therefore reported only as secondary exploratory analysis. These findings support technical feasibility for a constrained case-level classification task using preselected chest CT images, but do not demonstrate detection of unsuspected incidental breast cancer across complete CT examinations. Performance estimates remain uncertain, and external validation using complete volumetric CT data is required before clinical use.
Full article
(This article belongs to the Section Medical Research)
►▼
Show Figures

Figure 1
Open AccessArticle
A Methodological Framework for Non-Invasive Body-Composition Phenotyping in Young Adults: Integrating Bioelectrical Impedance and Patient Similarity Networks
by
Róbert László Nagy, Bence Bombera, Csongor István Szepesi, Nóra Horváth, Viktor Rekenyi and László Róbert Kolozsvári
Life 2026, 16(8), 1336; https://doi.org/10.3390/life16081336 - 14 Aug 2026
Abstract
Body mass index (BMI) does not capture fat distribution or muscle–fat heterogeneity, so adverse patterns go undetected. We present a methodological framework—not a validated prediction tool—combining three laboratory-free constructs: an Office-Based Framingham cardiovascular risk score, a modified proxy-based FINDRISC, and a direct segmental
[...] Read more.
Body mass index (BMI) does not capture fat distribution or muscle–fat heterogeneity, so adverse patterns go undetected. We present a methodological framework—not a validated prediction tool—combining three laboratory-free constructs: an Office-Based Framingham cardiovascular risk score, a modified proxy-based FINDRISC, and a direct segmental multi-frequency bioelectrical impedance analysis (DSM-BIA)-derived Metabolically Unhealthy Obesity (MUO) index, with a weighted patient similarity network. We tested six predefined hypotheses in 1684 young adults (mean age 22.5 ± 8.3 years; 50.2% female). Framingham was applied off-label below 30 years, so its outputs give only relative within-cohort ordering; unavailable FINDRISC items were scored zero, so standard FINDRISC categories do not apply. BMI-defined obesity occurred in 6.9%, high visceral fat in 21.7%, high MUO in 21.8%, a BIA-defined TOFI (thin outside, fat inside)-like phenotype in 5.2%, and a sarcopenic-obesity-like phenotype in 9.9%. Visceral fat correlated with percent body fat (r = 0.855). The network resolved nine interpretable communities (modularity Q = 0.63; permutation p = 0.005), including a BIA-defined TOFI-like community (cross-validated AUC = 0.93); k-means, hierarchical, PCA and UMAP clustering recovered convergent axes. All hypotheses were supported, indicating internal construct consistency, not external validation. Laboratory, imaging and longitudinal validation is required before any diagnostic or prognostic claim.
Full article
(This article belongs to the Special Issue Advances in Vascular Health and Metabolism—2nd Edition)
►▼
Show Figures

Figure 1
Open AccessArticle
Design, Synthesis and Biological Evaluation of Novel Oleanolic Acid Derivatives as Potential Anti-Leukemic Agents
by
Nefise Demir, Halilibrahim Ciftci, Khaled M. Elamin, Mustafa Can and Belgin Sever
Life 2026, 16(8), 1335; https://doi.org/10.3390/life16081335 - 14 Aug 2026
Abstract
Background: Chronic myeloid leukemia (CML) and other leukemia subtypes remain significant hematological malignancies that require the development of novel therapeutic agents with improved efficacy and selectivity. This study aimed to design, synthesize, and evaluate novel oleanolic acid (OA) derivatives as potential anti-leukemic agents.
[...] Read more.
Background: Chronic myeloid leukemia (CML) and other leukemia subtypes remain significant hematological malignancies that require the development of novel therapeutic agents with improved efficacy and selectivity. This study aimed to design, synthesize, and evaluate novel oleanolic acid (OA) derivatives as potential anti-leukemic agents. Methods: Structural modifications at the C-28 position afforded halogenated benzyl ester derivatives (MT-A–D), while aromatic acyl substitutions at the C-3 position generated derivatives NOA-1–16. The cytotoxic effects of the synthesized compounds were evaluated against K562, HL-60, Jurkat, and MT-2 leukemia cell lines and healthy PBMCs using the MTT assay. Apoptosis induction and ABL tyrosine kinase (TK) inhibition were also investigated. Molecular docking, MM/GBSA binding free energy calculations, and molecular dynamics (MD) simulations were performed to characterize ligand-enzyme interactions and binding stability. Results: MT-A exhibited the highest activity against HL-60 cells (IC50 = 4.17 ± 0.65 μM), surpassing imatinib (IC50 = 13.34 ± 1.92 μM). NOA-8 was the most potent compound against Jurkat and MT-2 cells, with IC50 values of 6.81 ± 1.08 μM and 2.48 ± 0.88 μM, respectively. MT-A, MT-C, NOA-3, and NOA-8 displayed IC50 values above 300 μM in PBMCs, indicating favorable selectivity. MT-A and MT-C induced significant apoptosis in K562 cells, while kinase assays revealed moderate ABL TK inhibition by these compounds. Docking, MM/GBSA, and MD analyses supported stable binding of MT-A and MT-C within the ABL ATP-binding pocket. Conclusions: MT-A, MT-C, NOA-3, and particularly NOA-8 emerged as promising anti-leukemic lead compounds with potent antiproliferative activity and favorable selectivity profiles, warranting further investigation for leukemia therapy.
Full article
(This article belongs to the Special Issue Hybrid Molecules in Drug Discovery: From Antidiabetic Agents to Anticancer Therapeutics)
►▼
Show Figures

Figure 1
Journal Menu
► ▼ Journal Menu-
- Life Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserHighly Accessed Articles
Latest Books
E-Mail Alert
News
Topics
Topic in
Geriatrics, IJMS, Life, Sports, Neurology International, Obesities
Exercise and Human Aging: Physiological and Psychological Functions
Topic Editors: Samuel Da Silva Aguiar, Ismael Perez-SuarezDeadline: 20 September 2026
Topic in
Nutrients, Metabolites, Healthcare, Children, Obesities, Life
Non-Communicable Diseases Silent Killer: Metabolic and Obesity Risks of Sedentary Behaviors
Topic Editors: Kotsedi Daniel Monyeki, Machoene Derrick SekgalaDeadline: 30 September 2026
Topic in
Molecules, Biomimetics, Chemosensors, Life, AI, Sci
Recent Advances in Chemical Artificial Intelligence
Topic Editors: Pier Luigi Gentili, Jerzy Górecki, David C Magri, Pasquale StanoDeadline: 15 October 2026
Topic in
Cells, IJMS, Metabolites, Physiologia, Life
Animal Models of Human Disease 3.0
Topic Editors: Sigrun Lange, Jameel M. InalDeadline: 31 October 2026
Conferences
Special Issues
Special Issue in
Life
Advances in Geriatric Medicine: Risk Assessment, Biomarkers, and Management Strategies
Guest Editors: Nadya Kagansky, Yochai LevyDeadline: 18 August 2026
Special Issue in
Life
Current Research on Dermatology: Pathology, Clinical Manifestation, Investigation and Therapy—Third Edition
Guest Editor: Alin Laurentiu TatuDeadline: 18 August 2026
Special Issue in
Life
Biomarkers, Neuromodulation and Neuroregulation for Diagnosis and Treatment of Brain Disorders
Guest Editors: Ciprian Ionuț Băcilă, Mihnea Costin ManeaDeadline: 18 August 2026
Special Issue in
Life
Challenges and Innovations in Biomaterials for Tissue Engineering
Guest Editors: Fei Fan, Donny Hanjaya-Putra, Loan BuiDeadline: 20 August 2026
Topical Collections
Topical Collection in
Life
Antimicrobial Resistance
Collection Editors: Caterina Aurilio, Antonella Paladini, Pasquale Sansone, Vincenzo Pota
Topical Collection in
Life
Heart Failure and Heart Transplantation
Collection Editors: Rasmus Rivinius, Andreas Doesch, Daniel Oehler
Topical Collection in
Life
State of the Art in Plant Science
Collection Editors: Kousuke Hanada, Yoshiteru Noutoshi


